Foligraf 75 IU
Available Dosages
| SKU | 1932 |
|---|---|
| Generic For | Follistim AQ |
| Strength | 75 IU |
| Active Ingredient | Recombinat Human |
Out Of Stock
Foligraf 75 IU – Affordable Follistim AQ Alternative for Infertility Treatment
Foligraf 75iu comprises of human follicle stimulating hormone (FSH), which is a glycoprotein hormone manufactured by recombinant DNA technology. FSH helps in stimulating ovaries to make eggs in females who have fertility issues. FSH does not help in a condition called primary ovarian failure. Foligraf is supplied in the form of injection for intravenous use.
Uses of Foligraf
Foligraf is useful in treating:
- Polycystic syndrome
- PCOD
- Infertility in female
Contraindications
- Foligraf should not be used in patients with known hypersensitivity to Foligraf or any other ingredients of the formulation.
- Its use is contraindicated in case of tumors of the hypothalamous and pituitary gland
- The medicine should not be used in women with uterine, ovarian, or mammary carcinoma.
- Do not use it if you have gynaecological haemorrhages of unkown etiology.
- The use of Foligraf injection is contraindicated in ovarian enlargement or cyst not due to polycystic disease.
- It is not indicated for pregnant women.
- The medicine is not for lactating mothers.
Side effects:
The side effects associated with the usage of Folligraf 75 IU are given below:
- Headache
- Ovarian cysts
- Mild to moderate OHSS
- Mild to severe injection site reaction such as redness, swelling, irritation, pain, and bruising at the site of injection.
- Abdominal pain
- Gastrointestinal issues such as diarrhea, abdominal cramps, vomiting, and bloating.
Medication interaction:
Like any other drug, Foligraf injection can also affect the working of other drugs. Therefore, it is necessary to inform your physician about all your medications that are using during Foligraf treatment.
- Coadministration with other drugs that are used to stimulate ovulation may potentiate the follicular response.
- Concurrent use of GnRH agonist may affect the mode fo action of foligraf
No other drug interaction has been reported during Foligraf treatment.
Usage instructions
Make sure that you read all the instructions and directions before using Foligraf injection. You must use it exactly as your physician tells you to. While prescribing the medicine, your physician will tell you how to inject it, how much to inject and when to inject the medicine. Avoid injecting at your home untill your physician has demonstrated the way to inject the medicine. You are not allow to change the dose of medicine without consulting with your physician. Immediately call your nearest medical center if you inject too much medicine.
In case you forget to adminstert Foligraf 75 IU, do not adminster two times to compensate the missed one. Ask your physician for more information.
Storage information
- Store the injection in the refrigerator
- Keep it away from light and heat
- Do not freeze the medicine
What is Recombinant Human FSH and what condition does it treat?
Recombinant Human FSH (follicle-stimulating hormone) is a fertility medication used to treat infertility in both women and men. Foligraf 75 IU contains this synthetic hormone, which mimics the natural FSH produced by the pituitary gland. In women, this gonadotropin helps stimulate ovarian follicle development for assisted reproductive techniques like IVF or ovulation induction. In men, it supports sperm production when combined with other fertility treatments. This injectable hormone therapy is prescribed when natural FSH levels are insufficient for normal reproductive function.
How does Recombinant Human FSH work in the body?
Recombinant Human FSH works by binding to FSH receptors on ovarian follicles in women or testicular cells in men, triggering reproductive processes. Foligraf 75 IU delivers this follicle-stimulating hormone directly into the bloodstream through injection. In female patients, the medication promotes multiple follicle growth and maturation, increasing egg production for fertility treatments. The gonadotropin signals the ovaries to prepare eggs for ovulation or retrieval. In males, it stimulates Sertoli cells in the testes to support spermatogenesis. This recombinant hormone replacement therapy effectively compensates for low or absent natural FSH production.
How long does Foligraf 75 IU take to work?
Foligraf 75 IU typically begins stimulating follicle growth within 7-14 days of starting treatment, though individual response varies. Most patients undergoing ovulation induction with this recombinant FSH medication will have follicles monitored via ultrasound after one week of injections. For IVF cycles, the fertility hormone usually requires 10-12 days of daily administration before egg retrieval. Men using this gonadotropin therapy for sperm production may need several months of continuous treatment before seeing improvements. Your fertility specialist will track your progress through blood tests and imaging to determine optimal response timing.
When and how should I take Foligraf 75 IU?
Foligraf 75 IU is administered as a subcutaneous injection, typically once daily at the same time each day. Your fertility doctor will prescribe the exact dosage and schedule based on your treatment protocol and ovarian response monitoring. This recombinant hormone injection is usually given in the abdomen or thigh using a small needle. Most patients begin injections on day 2 or 3 of their menstrual cycle for ovulation induction or IVF stimulation. Always follow your healthcare provider's specific instructions, as timing and dosage adjustments are critical for this gonadotropin therapy's success.
Is Foligraf 75 IU safe for long-term use?
Foligraf 75 IU is designed for short-term fertility treatment cycles rather than continuous long-term use. Most women use this recombinant FSH medication for 7-14 days per cycle during ovulation induction or IVF protocols. Men with hypogonadotropic hypogonadism may require extended treatment spanning several months to stimulate sperm production. The gonadotropin therapy is generally well-tolerated during prescribed treatment periods. Long-term safety depends on proper medical supervision, regular monitoring of hormone levels, and ultrasound tracking to prevent ovarian hyperstimulation syndrome. Your fertility specialist will determine appropriate treatment duration based on individual response and reproductive goals.
Can I take Foligraf 75 IU with other medicines?
Foligraf 75 IU can often be combined with other fertility medications as part of your assisted reproduction protocol. This recombinant hormone is frequently used alongside hCG injections, GnRH agonists, or antagonists in controlled ovarian stimulation cycles. However, inform your fertility specialist about all medications, supplements, and herbal products you're taking, as some may affect this gonadotropin therapy's effectiveness. Certain drugs impacting hormone levels or ovarian function may require dosage adjustments. Your reproductive endocrinologist will create a comprehensive medication plan ensuring safe, effective coordination between Foligraf and any concurrent fertility treatments or other prescriptions.
How does Foligraf 75 IU compare to similar medicines in its class?
Foligraf 75 IU belongs to the recombinant FSH class of fertility medications, comparable to other gonadotropins like Gonal-F, Puregon, and Bravelle. The key advantage of recombinant human FSH products like Foligraf is their high purity and consistency compared to urinary-derived alternatives. This fertility hormone offers precise dosing with minimal batch variation, potentially reducing injection site reactions. Clinical studies show similar pregnancy success rates across recombinant FSH brands when properly dosed. Foligraf's 75 IU strength provides flexibility for individualized treatment protocols. Cost differences and insurance coverage often influence choice between equivalent gonadotropin preparations.
Is generic Recombinant Human FSH as effective as branded versions?
Generic recombinant human FSH medications demonstrate equivalent effectiveness to branded versions like Foligraf 75 IU in clinical studies. All pharmaceutical-grade gonadotropin products must meet strict regulatory standards for purity, potency, and bioequivalence. The active follicle-stimulating hormone in generics produces the same biological effects as brand-name fertility treatments when properly manufactured. Clinical pregnancy rates and follicular response show no significant differences between branded and generic recombinant FSH preparations. Quality-assured generic options provide cost-effective access to this essential fertility medication without compromising treatment outcomes. Your reproductive specialist can recommend suitable generic alternatives based on availability and your specific protocol.
Why do patients choose PremiumRxDrugs for Foligraf 75 IU?
Patients select PremiumRxDrugs for Foligraf 75 IU because of the pharmacy's reputation for supplying genuine fertility medications at competitive prices. As a licensed international pharmacy, we source only authentic recombinant human FSH directly from manufacturers, ensuring quality and potency for sensitive fertility treatments. Customers appreciate the discreet packaging that protects privacy during gonadotropin therapy deliveries to the USA, UK, Australia, Canada, and beyond. The easy prescription management and reorder system proves invaluable during multi-cycle fertility protocols. With over ten years of service in the fertility community, free shipping options, and responsive support, PremiumRxDrugs provides reliable access to essential reproductive medications.
What are the common side effects of Recombinant Human FSH?
Common side effects of Recombinant Human FSH include injection site reactions like redness, swelling, or mild discomfort. Many patients experience headaches, abdominal bloating, or mood changes during this gonadotropin therapy. Women may notice breast tenderness or pelvic discomfort as follicles develop under the fertility hormone stimulation. Mild nausea and fatigue occasionally occur. More serious but less common reactions include ovarian hyperstimulation syndrome, characterized by severe abdominal swelling and rapid weight gain. Multiple pregnancies represent another potential outcome of follicle-stimulating hormone treatment. Most side effects resolve after completing the medication cycle.
Who should avoid taking Recombinant Human FSH?
Recombinant Human FSH should be avoided by individuals with primary ovarian failure, uncontrolled thyroid disorders, or adrenal dysfunction. Women with ovarian cysts unrelated to polycystic ovary syndrome, hormone-dependent tumors, or unexplained vaginal bleeding should not use this gonadotropin medication. This fertility hormone is contraindicated during pregnancy. Men with testicular cancer or other malignancies affecting reproductive organs shouldn't receive this follicle-stimulating hormone therapy. Patients with known hypersensitivity to FSH preparations or any medication components must avoid use. Those with uncontrolled pituitary or hypothalamic tumors require alternative fertility treatments under specialized endocrine care.
Login
Sign Up
Login
Sign Up